Viewing Study NCT00044304

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:51 PM
Ignite Modification Date: 2026-06-21 @ 11:11 PM
Study NCT ID: NCT00044304
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2002-08-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Eosinophilic Myeloid Neoplasm View
None Hypereosinophilic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Janus Kinase View
None Imatinib View
None Ruxolitinib View
None Myeloid Neoplasm View
None Platelet-Derived Growth Factor Receptor Alpha View
None Hypereosinophilic Syndrome View
None HES View